Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart
Open accessThe DOI matches its Crossref record; 334 of the 340 references it cites were found in a registry or an index.
Abstract
Despite the significant decline in mortality, cardiovascular diseases are still the leading cause of death worldwide. Among them, myocardial infarction (MI) seems to be the most important. A further decline in the death rate may be achieved by the introduction of molecularly targeted drugs. It seems that the components of the PI3K/Akt signaling pathway are good candidates for this. The PI3K/Akt pathway plays a key role in the regulation of the growth and survival of cells, such as cardiomyocytes. In addition, it has been shown that the activation of the PI3K/Akt pathway results in the alleviation of the negative post-infarct changes in the myocardium and is impaired in the state of diabetes. In this article, the role of this pathway was described in each step of ischemia and subsequent left ventricular remodeling. In addition, we point out the most promising substances which need more investigation before introduction into clinical practice. Moreover, we present the impact of diabetes and widely used cardiac and antidiabetic drugs on the PI3K/Akt pathway and discuss the molecular mechanism of its effects on myocardial ischemia and left ventricular remodeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the cardiovascular system, GLP-1 can reduce cardiac ischemia-reperfusion injury through the activation of specific signaling pathways, such as the PI3K/Akt pathway.437,438”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [437]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Sun, L., Wang, H., Xu, D., Yu, S., Zhang, L., & Li, X. (2021) · Bioengineered · doi:10.1080/21655979.2021.2004980 · Cited by 136 · cited 1×
“[102] demonstrated in a cardiomyocyte (H9c2) cell culture that PI3K/Akt activation has a cardioprotective effect by reducing oxidative stress and inhibiting ferroptosis induced by doxorubicin (DOX) and lapatinib (LAP) [103,104].”
BackgroundRetractedSun, G., Lü, Y., Li, Y., Mao, J., Zhang, J., Jin, Y., Li, Y., Sun, Y., Liu, L., & Li, L. (2017) · Bioscience Reports · doi:10.1042/bsr20170899 · Cited by 36 · cited 1×
“miR-19 MiR-19a protects H9C2 cardiomyocytes against H/R-induced apoptosis by inhibiting PTEN [292]; MiR-19b promotes NRCFs proliferation and migration by targeting PTEN [293].”
BackgroundRetractedZhang, Z.-W., Li, H., Cui, Z., Zhou, Z., Chen, S., Ma, J., Hou, L., Pan, X., & Li, Q. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1652630 · Cited by 24 · cited 1×
“miR-122 up [295,301] Aggravates oxygen–glucose deprivation and reperfusion apoptosis of H9C2 cardiomyocytes inhibiting AKT/GSK-3β/β-catenin and AKT/mTOR pathway signaling [302,303];”
BackgroundRetractedGong, L., Chang, H. H., & Xu, H. (2019) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.104325 · Cited by 9
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853 · cited 11×
“In turn, the overexpression of PTEN can be observed during MI, which inhibits the PI3K/Akt pathway and thus causes the opposite effect on IL-10, TNF-α, and MMP-2 expression, and in addition increases leukocyte infiltration in the myocardium and increases cardiomyocyte mortality.”
BackgroundInfluentialIbanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 2×
“observed that mTORC1 in vitro inhibits autophagosome formation by phosphorylation of unc-51-like autophagy activating kinase 1 (Ulk1) at Ser757 [186].”
Background
Cited by
Items 101–117 of 117
Mendonce, K. C., Srinivasan, M., Mohan, A., Altaf, R. R. S., Nithya, T. G., Annamalai, S. K., Ramar, R. K., & Rajadesingu, S. (2026) · ChemistrySelect · doi:10.1002/slct.202506099
Omar, H., Abdul‐Hafez, A., Thiruvenkataramani, R. P., Karanje, S., Ibrahim, S. A. E.-F., Mohammadi, S. J., Madhukar, B. V., & Omar, S. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27094053 · Cited by 1
“EVs also help to modulate the Wnt/ β -catenin pathway, thereby increasing fibroblast production and deposition, promoting dermal production [104,105].”
Bosukonda, D., Subramanian, R. R., Keck, P. C., Bey, P., Carlson, F. R., & Carlson, W. D. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1729074
Atmojo, S., Siswanto, B. B., Siregar, N. C., Kekalih, A., Saputri, F. C., Pikir, B. S., Noviana, D., Nurhafizah, A., Huang, W., & Wuyung, P. E. (2026) · Life · doi:10.3390/life16071198
“AKT is a key component of the PI3K/AKT survival pathway and plays an important role in cardiomyocyte survival, anti-apoptotic signaling, and adaptation to metabolic stress [19,20].”
Fayez, A. G., Esmaiel, N. N., Raouf, H. A., Aboelenin, M. M., Aly, R. M., & Eldeen, G. N. (2026) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2026.100757
“7 ,8 – 11 Phosphatidylinositol-3,4,5-trisphosphate (PIP3), produced by PI3K , orchestrates multiple downstream intracellular signaling events regulating cell growth, proliferation, and.”
FGF21 in coronary artery disease: Molecular mechanisms and therapeutic potential
Thakur, A., Chandel, P., & Bala, K. (2026) · Human Gene · doi:10.1016/j.humgen.2026.201586
Wang, N., Wang, H., Zhang, F., Zhu, H., Ren, Z., & Zheng, L. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05724-9
Zhang, S., Liu, S., Zhou, M., Wang, J., Zhang, Y., Zhong, H., & Ning, G. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06090-6
“In the cardiovascular system, GLP-1 attenuates myocardial ischemia–reperfusion injury, in part through the activation of pathways such as the PI3K/Akt pathway [104, 105 ].”
Sasmita, B. R., Huang, B., Yang, J., Luo, S., & Guo, Y. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107637
Zhu, T., Xie, C., Shao, Q., Zhou, S., Liang, Y., & Tang, X. (2026) · Molecular Immunology · doi:10.1016/j.molimm.2026.08.012
Sigma-1 receptor (S1R): Advancing therapeutic strategies in targeting ischemia
Mohan, M., Mannan, A., & Singh, T. G. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156688
Cellular Mechanisms Enabling Mitochondria Transfer and Transplantation
GÖKDEMİR, F. Ş., Ozendi, Y., Kubat, G. B., & Singh, K. K. (2026) · Advanced Science · doi:10.1002/advs.78137
Amir, M., Khalid, M., Zaheer, L., Nazar, S., Khursheed, M. A., Hussain, M., & Ahmad, T. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12872-x
“Sometimes hypoxic conditions, hormones that stimulate growth, and the presence of insulin may trigger PI3K/AKT, which boosts angiogenesis, cell viability, and decreases the size of infarcts [ 46–49 ].”
Citicoline in cardiovascular protection: mechanistic roles of choline and acetylcholine
García‐Niño, W. R., González‐Pacheco, H., & Zazueta, C. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118551
Inhibition of PI3K or AKT Differently Regulates Mesodermal Differentiation in P19CL6 Cells
Jiang, S., Li, Y., Yang, M., Wang, J., Chen, Z., Zhang, S., Li, Y., & Li, T. (2026) · Biology · doi:10.3390/biology15201887
“The tumor suppressor gene PTEN acts as a negative regulator of the PI3K-AKT pathway by dephosphorylating PIP3 back to PIP2, thereby terminating downstream signaling [11–13].”
Shaaban, E. M., Elnaggar, M. F., Abdelgawad, A., sedeek, M., Estfanos, S., & Eladl, O. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118573
Metadata
- Authors
- Walkowski, B., Kleibert, M., Majka, M., & Wojciechowska, M.
- Affiliations
- Medical University of Warsaw (PL)
- Corresponding author
- Kleibert, Marcin
- Majka, Miłosz
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-05-05
- Volume
- 11
- Issue
- 9
- Pages
- 1553
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC9105930
- OpenAlex
- W4280571486
- Cited by
- 117
- References
- 340
- Citations by year
- 2026: 27 · 2025: 31 · 2024: 28 · 2023: 28 · 2022: 3
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Publishing Fund of the Medical University of Warsaw (1MA/N/2022)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- PI3K/Akt signaling, myocardial ischemia, myocardial infarction, diabetic cardiomyopathy, diabetic heart, cardiomyocyte survival, molecularly targeted agents, antidiabetic drugs, cardiovascular drugs
- MeSH terms
- Diabetes Mellitus, Humans, Myocardial Infarction, Apoptosis, Phosphatidylinositol 3-Kinases, Ventricular Remodeling, Myocytes, Cardiac, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.